PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
14.60%
Revenue growth 50-75% of ORCL's 21.63%. Martin Whitman would scrutinize if slower growth is temporary.
27.05%
Cost growth above 1.5x ORCL's 8.85%. Michael Burry would check for structural cost disadvantages.
9.44%
Gross profit growth below 50% of ORCL's 24.64%. Michael Burry would check for structural issues.
-4.50%
Margin decline while ORCL shows 2.48% expansion. Joel Greenblatt would examine competitive position.
13.85%
R&D growth above 1.5x ORCL's 3.71%. Michael Burry would check for spending discipline.
17.75%
G&A growth above 1.5x ORCL's 5.58%. Michael Burry would check for operational inefficiency.
32.19%
Marketing expense growth 1.25-1.5x ORCL's 22.53%. Martin Whitman would scrutinize spending rationale.
8.33%
Other expenses growth less than half of ORCL's 118.89%. David Dodd would verify if advantage is sustainable.
23.18%
Operating expenses growth above 1.5x ORCL's 12.42%. Michael Burry would check for inefficiency.
24.90%
Total costs growth above 1.5x ORCL's 11.34%. Michael Burry would check for inefficiency.
-3.43%
Interest expense reduction while ORCL shows 5.26% growth. Joel Greenblatt would examine advantage.
38.80%
D&A growth above 1.5x ORCL's 0.94%. Michael Burry would check for excessive investment.
21.71%
EBITDA growth 50-75% of ORCL's 34.02%. Martin Whitman would scrutinize operations.
-11.37%
EBITDA margin decline while ORCL shows 10.19% growth. Joel Greenblatt would examine position.
-7.05%
Operating income decline while ORCL shows 37.94% growth. Joel Greenblatt would examine position.
-18.90%
Operating margin decline while ORCL shows 13.41% growth. Joel Greenblatt would examine position.
658.82%
Other expenses growth while ORCL reduces costs. John Neff would investigate differences.
-5.46%
Pre-tax income decline while ORCL shows 41.21% growth. Joel Greenblatt would examine position.
-17.51%
Pre-tax margin decline while ORCL shows 16.10% growth. Joel Greenblatt would examine position.
51.50%
Tax expense growth 1.25-1.5x ORCL's 37.72%. Martin Whitman would scrutinize strategy.
-18.52%
Net income decline while ORCL shows 42.14% growth. Joel Greenblatt would examine position.
-28.90%
Net margin decline while ORCL shows 16.87% growth. Joel Greenblatt would examine position.
-17.65%
EPS decline while ORCL shows 42.11% growth. Joel Greenblatt would examine position.
-19.12%
Diluted EPS decline while ORCL shows 42.86% growth. Joel Greenblatt would examine position.
-0.46%
Both companies reducing share counts. Martin Whitman would check patterns.
-0.26%
Both companies reducing diluted shares. Martin Whitman would check patterns.